Abstract
The leukocyte-specific integrin CD11b/CD18 plays a key role in the biological function of these cells and represents a validated therapeutic target for inflammatory diseases. Currently, the low affinity interaction between CD11b/CD18 integrin and its respective ligand poses a challenge in the development of cell-based adhesion assays for the high-throughput screening (HTS) environment. Here the authors describe a simple cell-based adhesion assay that can be readily used for HTS for the discovery of functional regulators of CD11b/CD18. The assay consistently produces acceptable Z' values (> 0.5) for HTS. After testing the assay using 2 established blocking antibodies as reference biologicals, the authors performed a proof-of-concept primary screen using a library of 6612 compounds and identified both agonist and antagonist hits.
Original language | English (US) |
---|---|
Pages (from-to) | 406-417 |
Number of pages | 12 |
Journal | Journal of Biomolecular Screening |
Volume | 12 |
Issue number | 3 |
DOIs | |
State | Published - Apr 2007 |
Externally published | Yes |
Keywords
- Cell adhesion assay
- Integrin
- No-wash assay
- Primary screen
ASJC Scopus subject areas
- Analytical Chemistry
- Biotechnology
- Biochemistry
- Molecular Medicine
- Pharmacology
- Drug Discovery